CClinicalTrials.gg
CompletedNCT04012112Updated Jul 22, 2020

The Effect of Flexible Thoracolumbar Brace on Spinal Alignment, Pain and Quality of Life in Subjects With Neuromuscular Scoliosis

An interventional study of thoracolumbar brace (Flexpine brace) in Neuromuscular Scoliosis, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 3 Years to 18 Years. Per ClinicalTrials.gov, last updated 2020-07-22.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Aug 2018, registered Jun 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
3 Years to 18 Years
Sex
All
01

Study summary

In the initial evaluation, the degree of spine is measured quantitatively using Cobb's angle and Muscular Dystrophy Spine Questionnaire (MDSQ). The patients who had Cobbs angle of 20-45 'by spinal plain radiography were evaluated for the effects of flexpine brace wearing and rehabilitation for 6 months. After 12 months, whole spine X-ray was taken for the followed up the patient's status.

02

Conditions studied

  • Neuromuscular Scoliosis

Browse trials for

Keywords

  • brace
  • neuromuscular disease
  • scoliosis
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 12 is below the median of 44 across 344 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 20-45' degrees of cobb's angle in the neuromuscular disease

Exclusion criteria

Exclusion Criteria:

  • patient's who had spinal surgery
  • less than 20 degree or more than 45 degree of cobb's angle
  • acute lumbar pain
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    single-arm trials

    longitudial study of the thoracolumbar brace in the neuromuscular scoliosis for 6 months

    Device: thoracolumbar brace (Flexpine brace)

Interventions

  • Devicethoracolumbar brace (Flexpine brace)

    Patient's would wear the FLEXpine brace over 18 hours a day for the 6 month

06

What researchers measure

Primary outcomes

  1. change of the scoliosis

    Cobb's angle in the whole spine anteroposterior view of X-ray before, immediately after, and 6-month after wearing FLEXpine brace

    Time frame: 6months

Secondary outcomes

  1. change of pain

    pain scale checked through the visual analog scale

    Time frame: 6months

  2. change of pulmonary function

    assessed by spirometer of forced vical capacity

    Time frame: 6 months

  3. change of quality of life

    Parents assessed the quality of life through the muscular dystrophy spine qusetionnaire

    Time frame: 6 months

07

Study locations

1 site
  • Seoul national university bundang hospital
    Seongnam-si, Bundang 13364, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04012112
Lead sponsor
Seoul National University Hospital
Responsible party
Ju Seok Ryu (associate professor, Seoul National University Hospital) — Principal investigator
First posted
Jul 9, 2019
Start date
Aug 23, 2018
Primary completion
Jun 30, 2019
Completion
Jun 30, 2019
Last update
Jul 22, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion